Department of Gastroenterology, Changzhou No. 2 Hospital, Affiliated with Nanjing Medical University, Changzhou, China.
PLoS One. 2013 Jun 12;8(6):e65731. doi: 10.1371/journal.pone.0065731. Print 2013.
Genetic polymorphisms of Toll-like receptors (TLRs) may influence the effects of H. pylori infection and play important roles in gastric carcinogenesis. The aim of this study was to determine whether the polymorphisms of TLR4 and TLR9 are associated with susceptibility to gastric carcinoma and its prognosis.
This study consisted of 314 patients with gastric cancer and 314 healthy controls. The polymorphisms were assessed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Survival was analyzed by Kaplan-Meier survival curves.
No variant genotypes of TLR4+896A/G, TLR4+1196C/T, or TLR9 -1237T/C were detected. For TLR9 -1486 T/C, multiple logistic regression analyses revealed that compared with the TT homozygote, patients with both the TC variant (adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.04-2.10) and the CC variant (adjusted OR = 1.63, 95% CI = 1.01-2.64) had higher risks of gastric cancer. Further stratification analyses revealed that an increased risk of gastric cancer associated with C carriers was evident among females (adjusted OR = 1.84, 95%CI = 1.02-3.33), in younger subjects aged less than 60 years old (adjusted OR = 1.86, 95%CI = 1.15-3.00), and subjects with H. pylori infection (adjusted OR = 1.53, 95% CI = 1.03-2.27). We also observed a significant association between C carriers and noncardia gastric cancer (adjusted OR = 1.51, 95% CI = 1.03-2.20). In addition, we demonstrated that the C carrier genotype and H. pylori infection may have a synergistic effect and conferred an OR of 2.44 for developing gastric cancer. TLR9 -1486C was also identified as an independent marker of poor survival of carcinoma.
Our results suggest that TLR9 -1486C carriers are associated with an increased risk and poor prognosis of gastric carcinoma in the Chinese population.
Toll 样受体(TLR)的遗传多态性可能影响幽门螺杆菌感染的作用,并在胃癌发生中发挥重要作用。本研究旨在确定 TLR4 和 TLR9 的多态性是否与胃癌易感性及其预后相关。
本研究纳入 314 例胃癌患者和 314 例健康对照者。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法检测多态性。采用 Kaplan-Meier 生存曲线分析生存情况。
未检测到 TLR4+896A/G、TLR4+1196C/T 或 TLR9-1237T/C 的变异基因型。对于 TLR9-1486T/C,多因素逻辑回归分析显示,与 TT 纯合子相比,TC 变异(调整优势比(OR)=1.47,95%置信区间(CI)=1.04-2.10)和 CC 变异(调整 OR=1.63,95%CI=1.01-2.64)患者发生胃癌的风险更高。进一步分层分析显示,女性(调整 OR=1.84,95%CI=1.02-3.33)、年龄<60 岁(调整 OR=1.86,95%CI=1.15-3.00)和幽门螺杆菌感染(调整 OR=1.53,95%CI=1.03-2.27)患者中 C 携带者与胃癌风险增加相关。我们还观察到 C 携带者与非贲门胃癌之间存在显著关联(调整 OR=1.51,95%CI=1.03-2.20)。此外,我们发现 C 携带者基因型和幽门螺杆菌感染可能具有协同作用,发生胃癌的 OR 为 2.44。TLR9-1486C 还被确定为癌症患者生存不良的独立标志物。
我们的研究结果表明,TLR9-1486C 携带者与中国人群胃癌的风险增加和预后不良相关。